📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Bitopic Binding Mode of an M1 Muscarinic Acetylcholine Receptor Agonist Associated with Adverse Clinical Trial Outcomes. (2018)

First Author: Bradley SJ

Attributed to: MICA Pharmacological, molecular and cellular mechanisms of muscarinic slowing (modification) of neurodegenerative disease. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1124/mol.118.111872

PubMed Identifier: 29695609

Publication URI: http://europepmc.org/abstract/MED/29695609

Type: Journal Article/Review

Volume: 93

Parent Publication: Molecular pharmacology

Issue: 6

ISSN: 0026-895X